Reposting periodically. Pharma is ascertaining reversal after fours of downtrend. 50 DMA crossing 200 DMA-- Golden Cross. Pharma Majors such as Lupin, Cipla, DrReddy, Divis, SunPharma, PEL, Auro, Ajanta, Torrent, Cadila, Glenmark, Biocon (more in R&D)-- all are striding up after recent correction. One can think of investing if one more correction comes for medium to long term gain.